Observe Medical ASA: Interim report second quarter and first half year 2020
Oslo, 18 August 2020 – Observe Medical ASA (OSE: OBSERV) today released its interim report for the second quarter and first half year of 2020. The company’s initial product, Sippi, a unique and proprietary solution for digital automated urine monitoring in hospitals is in an early stage of commercialization. The company confirms its market estimate potential of 500,000 Sippi® base units and 30 million Sippi® disposable units per year. “The mission of Observe Medical is to improve the clinical outcome for patients and enable a more efficient care system, with Sippi® system by means of